StockWatch
·

LifeStance Health Group, Inc. Q1 FY26 Results

LFSTQ1 FY26 Results
Filing
MetricValue ($ M)Q1 FY25
Revenue403.4821.2%
Total Income403.4821.2%
Expenditure381.1915.0%
PBT19.761444.2%
Net Profit14.241905.6%
OPM5.52%5.04pp
NPM3.53%3.32pp
EPS
View full financials

LifeStance Reports Q1 2026 Revenue $403.5M, Up 21% Y/Y

07 May 2026 · 7 May, 3:39 pm

Summary

LifeStance Health Group reported strong first quarter 2026 results, with revenue increasing by 21% to $403.5 million. The company's clinician base grew by 11%, and visit volumes increased by 18%. Net income improved significantly to $14.2 million, and Adjusted EBITDA increased to $51.1 million. The company is raising its full year revenue expectations to $1.640 billion to $1.680 billion.

Key Highlights

  1. 1

    LifeStance Health Group's revenue of $403.5 million increased 21% compared to the prior year.

  2. 2

    The clinician base increased 11% to 8,349 clinicians, with a sequential net increase of 309 in the first quarter.

  3. 3

    First quarter visit volumes increased 18% to 2.5 million.

  4. 4

    Net income was $14.2 million, a significant increase from $0.7 million in the prior year.

  5. 5

    Adjusted EBITDA reached $51.1 million, compared to $34.6 million in the prior year.

  6. 6

    Net cash provided by operations was $33.1 million in the first quarter.

  7. 7

    The company is raising full year revenue expectations to $1.640 billion to $1.680 billion.

Management Comments

D

Dave Bourdon

We delivered an exceptional quarter to begin the year, highlighted by strong revenue growth of 21%, net income growth of $13.5 million, and Adjusted EBITDA growth of 48%.Our performance demonstrates that our differentiated model is meeting the societal trend of growing demand for mental healthcare. We also took an important step forward in our commitment to clinical excellence by announcing an outcomes study on approximately 180,000 LifeStance patients that showed roughly three quarters reported clinically significant improvement in anxiety and depression.

Informational and educational content only. Not investment advice.